Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PMS2P5 is an unprocessed pseudogene homologous to PMS2, a key component of the DNA mismatch repair system. It does not encode a functional protein and has no known enzymatic, signaling, or receptor activity. Pseudogenes like PMS2P5 are commonly found near functional genes such as PMS2 on chromosome 7, and while sometimes involved in gene regulation or recombination events, PMS2P5 itself lacks therapeutic relevance[1][2][4]. There is no evidence for a role in disease or cellular pathways, nor is it considered a valid target for drugs. Its high sequence similarity to PMS2 can complicate genetic analyses, as it may lead to incorrect assignment of mutations during genetic testing for disorders such as Lynch syndrome[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PMS1 homolog 2, mismatch repair system component pseudogene 5 (PMS2P5).